Now available for standard surgical risk patients

Now available for standard surgical risk patients

The TCAR® system from Silk Road Medical empowers surgeons with greater flexibility when treating carotid artery disease. With expanded indications for use for the ENROUTE® stent, more patients than ever can benefit from a less invasive procedure that protects patients from surgery-related stroke (with freedom from stroke as high as 99.4%).2 Compared to CEA, TCAR provides:

The TCAR® system from Silk Road Medical empowers surgeons with greater flexibility when treating carotid artery disease. With expanded indications for use for the ENROUTE® stent, more patients than ever can benefit from a less invasive procedure that protects patients from surgery-related stroke (with freedom from stroke as high as 99.4%).2 Compared to CEA, TCAR provides:

Less risk of stroke
with rate as low as 0.6%1

89% less risk
of cranial nerve injury3

47% less risk
of in-hospital MI2

40% less time
in the OR2

The Power of Less Invasive Stroke Prevention

With expanded indications for use, TCAR empowers surgeons with more flexibility when treating carotid artery disease. Now, more patients than ever can benefit from a less invasive procedure that takes less time to perform and results in significantly less risk of CNI and MI compared to CEA,* all while protecting the patient from surgery-related stroke (with freedom from stroke as high as 99.4%).**

Compelling Clinical Benefits

With powerful clinical and patient benefits, the TCAR® system enables a better experience for both high and standard surgical risk patients
undergoing treatment for atherosclerotic carotid artery disease.

Patients Prefer TCAR

Watch as a busy nurse manager discovers blockages in her carotid arteries and takes us on her journey through treatment with both CEA and TCAR.

Find Out More About How TCAR is Now THE Less Invasive Standard in Stroke Prevention

1. Kashyap VS, et al. ROADSTER 2 Investigators*. Early Outcomes in the ROADSTER 2 Study of Transcarotid Artery Revascularization in Patients with Significant Carotid Artery Disease. Stroke. 2020 Sep;51(9):2620-29.
2. Malas MB, et al. TransCarotid Revascularization with Dynamic Flow reversal versus Carotid Endarterectomy in the Vascular Quality Initiative Surveillance Project. Ann Surg. 2020 Sep 15. doi: 10.1097/SLA.0000000000004496. Epub ahead of print.
3. Liang P, et al. Expansion of Transcarotid Artery Revascularization to Standard Risk Patients for Treatment of Carotid Artery Stenosis. Oral presentation at the Vascular Annual Meeting; August, 2021; San Diego, CA.